Cabaletta Bio (CABA) Prepaid Assets (2018 - 2025)
Cabaletta Bio's (CABA) quarterly Prepaid Assets came in at $5.3 million in Q4 2025, up 94.32% year-on-year from $2.7 million in Q4 2024, and up 13.87% quarter-over-quarter from $4.6 million in Q3 2025.
Cabaletta Bio (CABA) Prepaid Assets (2018 - 2025) Analysis & Trends
Cabaletta Bio's Prepaid Assets history runs 8 years deep, the most recent figure standing at $5.3 million for Q4 2025.
- On a quarterly basis, Prepaid Assets rose 94.32% year-over-year to $5.3 million in Q4 2025; TTM through Dec 2025 was $5.3 million, a 94.32% increase from a year earlier, with the FY2025 full-year figure at $5.3 million, up 94.32% from the prior year.
- Prepaid Assets grew to $5.3 million in Q4 2025 per CABA's latest filing, from $4.6 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $5.3 million in Q4 2025 and bottomed at $1.2 million in Q2 2023.
- The 5-year median for Prepaid Assets is $2.4 million (2021), against an average of $2.8 million.
- Across the five-year window, Prepaid Assets tumbled 52.41% in 2021 and jumped 143.65% in 2024, its largest moves.
- Year by year, Prepaid Assets stood at $2.3 million in 2021, then dropped by 1.38% to $2.3 million in 2022, then soared by 41.71% to $3.2 million in 2023, then decreased by 16.29% to $2.7 million in 2024, then surged by 94.32% to $5.3 million in 2025.
- Per Business Quant, the three latest CABA Prepaid Assets figures stand at $5.3 million (Q4 2025), $4.6 million (Q3 2025), and $3.7 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn |
| 10 | Cabaletta Bio | 184.38 Mn | 184.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.27 Mn |
| Sep 30, 2025 | 4.63 Mn |
| Jun 30, 2025 | 3.73 Mn |
| Mar 31, 2025 | 2.77 Mn |
| Dec 31, 2024 | 2.71 Mn |
| Sep 30, 2024 | 2.50 Mn |
| Jun 30, 2024 | 3.03 Mn |
| Mar 31, 2024 | 3.64 Mn |
| Dec 31, 2023 | 3.24 Mn |
| Sep 30, 2023 | 1.79 Mn |
| Jun 30, 2023 | 1.24 Mn |
| Mar 31, 2023 | 1.89 Mn |
| Dec 31, 2022 | 2.29 Mn |
| Sep 30, 2022 | 2.28 Mn |
| Jun 30, 2022 | 1.94 Mn |
| Mar 31, 2022 | 2.23 Mn |
| Dec 31, 2021 | 2.32 Mn |
| Sep 30, 2021 | 1.59 Mn |
| Jun 30, 2021 | 2.21 Mn |
| Mar 31, 2021 | 3.73 Mn |